Jiang X - Search Results

1

The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.

Jiang X, Sun Q, Li H, Li K, Ren X. Jiang X, et al. Int J Cancer. 2014 Nov 1;135(9):1991-6. doi: 10.1002/ijc.28637. Epub 2013 Dec 9. Int J Cancer. 2014. PMID: 24285383 Review.

2

Correlation of genes associated with drug response to prognosis of large cell lung carcinoma.

Chen C, Jiang XL, Zhang CC, Li K. Chen C, et al. Chin J Cancer. 2011 Jul;30(7):497-504. doi: 10.5732/cjc.010.10503. Chin J Cancer. 2011. PMID: 21718596 Free PMC article.

3

The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases.

Jiang X, Liu Y, Chen C, Zhan Z, Yan Q, Guo Y, Wang Q, Li K. Jiang X, et al. Clin Lung Cancer. 2012 Jul;13(4):288-96. doi: 10.1016/j.cllc.2011.11.004. Epub 2011 Dec 13. Clin Lung Cancer. 2012. PMID: 22169481

4

Pemetrexed-based chemotherapy in advanced lung adenocarcinoma patients with different EGFR genotypes.

Jiang X, Yang B, Lu J, Zhan Z, Li K, Ren X. Jiang X, et al. Tumour Biol. 2015 Feb;36(2):861-9. doi: 10.1007/s13277-014-2692-4. Epub 2014 Oct 10. Tumour Biol. 2015. PMID: 25301443

5

High-mobility group nucleosome-binding protein 1 is a novel clinical biomarker in non-small cell lung cancer.

Wei F, Yang F, Jiang X, Yu W, Ren X. Wei F, et al. Among authors: jiang x. Tumour Biol. 2015 Dec;36(12):9405-10. doi: 10.1007/s13277-015-3693-7. Epub 2015 Jun 26. Tumour Biol. 2015. PMID: 26113410

6

Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis.

Sun Q, Li S, Wang Y, Peng H, Zhang X, Zheng Y, Li C, Li L, Chen R, Chen X, Bai W, Jiang X, Liu L, Wei F, Wang B, Zhang Y, Li H, Ren X, Zhang H. Sun Q, et al. Among authors: jiang x. Cell Death Differ. 2018 Jun;25(6):1160-1173. doi: 10.1038/s41418-017-0034-y. Epub 2018 Jan 23. Cell Death Differ. 2018. PMID: 29362480 Free PMC article.

7

CD31-labeled circulating endothelial cells as predictor in anlotinib-treated non-small-cell lung cancer: Analysis on ALTER-0303 study.

Liu Z, Wang J, Meng Z, Wang X, Zhang C, Qin T, Chen J, Jiang X, Wang L, Lin L, Zhang X, Chen P, Huang C, Jiang R, Li K. Liu Z, et al. Among authors: jiang r, jiang x. Cancer Med. 2018 Jul;7(7):3011-3021. doi: 10.1002/cam4.1584. Epub 2018 Jun 1. Cancer Med. 2018. PMID: 29856135 Free PMC article.

8

Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts.

Wang J, Guan X, Zhang Y, Ge S, Zhang L, Li H, Wang X, Liu R, Ning T, Deng T, Zhang H, Jiang X, Ba Y, Huang D. Wang J, et al. Among authors: jiang x. Cell Physiol Biochem. 2018;49(3):869-883. doi: 10.1159/000493218. Epub 2018 Sep 5. Cell Physiol Biochem. 2018. PMID: 30184548 Free article.

9

Comparison of Clinicopathological Features and Prognosis between ALK Rearrangements and EGFR Mutations in Surgically Resected Early-stage Lung Adenocarcinoma.

Li P, Gao Q, Jiang X, Zhan Z, Yan Q, Li Z, Huang C. Li P, et al. Among authors: jiang x. J Cancer. 2019 Jan 1;10(1):61-71. doi: 10.7150/jca.26947. eCollection 2019. J Cancer. 2019. PMID: 30662526 Free PMC article.

10

Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.

Wu Z, Liu Z, Jiang X, Mi Z, Meng M, Wang H, Zhao J, Zheng B, Yuan Z. Wu Z, et al. Among authors: jiang x. J Exp Clin Cancer Res. 2019 Aug 6;38(1):341. doi: 10.1186/s13046-019-1349-y. J Exp Clin Cancer Res. 2019. PMID: 31387622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,573 results

Search Page

Filters